Dergiler / Turkish Thoracic Journal / 2016 / Cilt: 17 - Sayı: 2

Use of High-Resolution Computed Tomography (HRCT) in Diagnosis of Sputum Negative Pulmonary Tuberculosis

Sayfa
59–64
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: HRCT is useful in selecting individuals with greater chances of PTB in the sputum smear-negative setting.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVES: To study the role of high-resolution computed tomography (HRCT) in the diagnosis of pulmonary tuberculosis (PTB) in sputum smear negative patients and to design HRCT criterion to forecast the threat of pulmonary tuberculosis.
📊
Temel Bulgular & Veri:MATERIAL AND METHODS: We studied 69 patients having sputum smear negative for acid-fast bacilli (AFB) but still with clinical suspicion of PTB after taking written informed consent.
💡
Sonuç & Katkı:CONCLUSION: HRCT is useful in selecting individuals with greater chances of PTB in the sputum smear-negative setting.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVES: To study the role of high-resolution computed tomography (HRCT) in the diagnosis of pulmonary tuberculosis (PTB) in sputum smear negative patients and to design HRCT criterion to forecast the threat of pulmonary tuberculosis. MATERIAL AND METHODS: We studied 69 patients having sputum smear negative for acid-fast bacilli (AFB) but still with clinical suspicion of PTB after taking written informed consent. We studied their medical characteristics, numerous separate HRCT-results and combination of HRCT findings to foresee the danger for PTB by utilizing univariate and multivariate investigation. Temporary HRCT diagnostic criteria were planned in view of these outcomes to find out the risk of PTB and tested these criteria on our patients. RESULTS: Chronic cough and night sweats were highly linked to a greater risk of PTB among clinical features. On HRCT chest presence of cavity, centrilobular nodules, consolidation, ground glass opacity (GGO), lymphadenopathy, main lesion in S1, S2, S6, lobular consolidation, other minute nodules and tree in bud appearance was significantly linked to an elevated risk of PTB in linear regression analysis. While cavity, centrilobular nodules, interlobular septal thickening, pleural effusion and tree-in-bud appearance was significantly linked to a greater threat of PTB in multivariate regression analysis. Positioning of the patients utilizing our HRCT indicative criteria uncovered reliable sensitivity and specificity for PTB patients determining that HRCT is a useful tool in sputum negative PTB patients. CONCLUSION: HRCT is useful in selecting individuals with greater chances of PTB in the sputum smear-negative setting.

🔖

Bu Makaleye Atıf Yap

RAGHUVANSHİ, V., SOOD, R. G., JHOBTA, A., SARKAR, M., TOMAR, A., KHANNA, S. (2016). Use of High-Resolution Computed Tomography (HRCT) in Diagnosis of Sputum Negative Pulmonary Tuberculosis. Turkish Thoracic Journal, Cilt: 17 - Sayı: 2, 59–64. https://ajindex.com/articles/418147

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Longo DL, Fauci AS, Kasper DL, et al. Tuberculosis. Harrison’s Principles of Internal Medicine. 18th ed. McGraw-Hill, 2012: Chapter 165:1340. [CrossRef] 2. WHO. Tuberculosis country profiles.[internet].2015[cited 2015 Jan 15]. Available from: http://www.who.int/tb/country/data/ profiles/en/ [CrossRef] 3. Sidiqi K, Lambert ML, Walley J. Clinical diagnosis of smearnegative pulmonary tuberculosis in low income countries: the current evidence. Lancet Infect Dis 2003;3:288-96. [CrossRef] 4. Kanaya AM, Glidden DV, Henry F. Identifying pulmonary tuberculosis in patients with negative sputum smear results. Chest 2001;120:349-55. [CrossRef] 5. Nakanishi M, Demura Y, Ameshima S, et al. Utility of high-resolution computed tomography for predicting risk of sputum smear-negative pulmonary tuberculosis. Eur J Radiol 2010;73:545-50. [CrossRef] 6. Zumla A, Raviglione M, Hafner R, et al. Current concepts: tuberculosis. N Engl J Med 2013;368:745-55. [CrossRef] 7. Chihota VN, Grant AD, Fielding K, et al. Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis 2010;14:1024-31. [CrossRef] 8. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med 2010;363:1005-15. [CrossRef] 9. Tozkoparan E, Deniz O, Ciftci F, et al. The roles of HRCT and clinical parameters in assessing activity of suspected smear negative pulmonary tuberculosis. Arch Med Res 2005;36:166-70. [CrossRef] 10. Devakonda A, Raoof S, Sung A, et al. Bronchiolar disorders a clinical-radiological diagnostic algorithm. Chest 2010;137:938-51. [CrossRef] 11. Lai FM, Liam CK, Paramsothy M, George J. The role of 67gallium scintigraphy and high resolution computed tomography as predictors of disease activity in sputum smear-negative pulmonary tuberculosis. Int J Tuberk Lung Dis 1998;1:563-9. [CrossRef] 12. Webb WR, Higgins CB. Solitary and multiple nodules, masses, cavities and cysts. Thoracic Imaging: pulmonary and cardiovascular radiology. 2nd ed. Lippincott Williams and Wilkins, 2011; Chapter 9:292. 13. Ikezoe J, Takeuchi N, Johkoh T, et al. CT appearance of pulmonary tuberculosis in diabetic and immunocompromised patients: comparison with patients who had no underlying disease. AJR 1992;159:1175-9. [CrossRef] 14. Yabuuchi H, Murayama S, Murakami J, et al. Correlation of immunologic status with high-resolution CT and distributions of pulmonary tuberculosis. Acta Radiol 2002;43:44-7. [Cro